Navigation Links
Isis Pharmaceuticals to Present at the 2012 Stifel Nicolaus Healthcare Conference
Date:8/30/2012

CARLSBAD, Calif., Aug. 30, 2012 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a company overview at the 2012 Stifel Nicolaus Healthcare Conference on Wednesday, September 5, 2012 at 11:30 a.m. ET in Boston.  In addition, Isis will participate in the Biotech Panel hosted by Stephen Willey scheduled on Wednesday, September 5, 2012 at 9:10 a.m. ET.

A live audio webcast of the presentation and panel will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com.  A replay will be available on the Isis Web site within 48 hours and will be archived for a limited time.

ABOUT ISIS PHARMACEUTICALS, INC.

Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 25 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, plans to commercialize Isis' lead product, KYNAMRO™, in the United States and Europe following regulatory approval.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

Forward-Looking Statements

This press release includes forward-looking statements regarding Isis' business and the therapeutic potential of Isis' technologies and products in development.  Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the planned commercialization of KYNAMRO, is a forward-looking statement and should be considered an
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)...  BioMed Realty Trust, Inc. (NYSE: ... on life sciences, today announced financial results for ... Third Quarter 2014 Highlights Financial and Operating ... during the quarter representing approximately 657,700 square feet, ... third quarter of approximately 219,700 square feet; and ...
(Date:10/27/2014)... Research and Markets has announced the ... report to their offering. H1N1 influenza (zoonotic) ... of the swine H1N1 virus, known as H1N1v virus. The ... and lungs. H1N1 virus is an RNA virus belonging to ... such as humans, swine, birds, seals, and horses. Influenza A ...
(Date:10/27/2014)... Research and Markets has announced the addition ... report to their offering. A service ... of tasks that might be simple or complex, time-consuming, ... broad divisions: Professional Robot and Personal/domestic Robot. Professional robots ... such as underwater applications, defense, and security and surveillance ...
Breaking Medicine Technology:BioMed Realty Trust Reports Third Quarter 2014 Financial Results 2BioMed Realty Trust Reports Third Quarter 2014 Financial Results 3BioMed Realty Trust Reports Third Quarter 2014 Financial Results 4BioMed Realty Trust Reports Third Quarter 2014 Financial Results 5BioMed Realty Trust Reports Third Quarter 2014 Financial Results 6BioMed Realty Trust Reports Third Quarter 2014 Financial Results 7BioMed Realty Trust Reports Third Quarter 2014 Financial Results 8BioMed Realty Trust Reports Third Quarter 2014 Financial Results 9BioMed Realty Trust Reports Third Quarter 2014 Financial Results 10BioMed Realty Trust Reports Third Quarter 2014 Financial Results 11BioMed Realty Trust Reports Third Quarter 2014 Financial Results 12BioMed Realty Trust Reports Third Quarter 2014 Financial Results 13BioMed Realty Trust Reports Third Quarter 2014 Financial Results 14BioMed Realty Trust Reports Third Quarter 2014 Financial Results 15BioMed Realty Trust Reports Third Quarter 2014 Financial Results 16BioMed Realty Trust Reports Third Quarter 2014 Financial Results 17BioMed Realty Trust Reports Third Quarter 2014 Financial Results 18BioMed Realty Trust Reports Third Quarter 2014 Financial Results 19BioMed Realty Trust Reports Third Quarter 2014 Financial Results 20BioMed Realty Trust Reports Third Quarter 2014 Financial Results 21Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3Global Service Robot Market 2014-2018: Key Vendors are GeckoSystem, Honda Motor, iRobot and Toyota Motor 2Global Service Robot Market 2014-2018: Key Vendors are GeckoSystem, Honda Motor, iRobot and Toyota Motor 3
... N.C. , April 22 The reporting of ... pharmaceutical industry and its importance is clear as the U.S. ... for adverse events. Yet when it comes to gray areas ... A Best Practices, LLC post-marketing surveillance study found that 50 ...
... /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals,Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company"), a growing,developer, ... (the "PRC"), today reported it will exhibit at the 63rd,PHARMCHINA. , , ... Venue: International Convention ... , , ...
Cached Medicine Technology:Best Practices, LLC Report on Post-Marketing Surveillance Programs Sheds Light on Gray Areas of Adverse Event Reporting 2Best Practices, LLC Report on Post-Marketing Surveillance Programs Sheds Light on Gray Areas of Adverse Event Reporting 3Lotus Pharmaceuticals to Exhibit at the 63rd PHARMCHINA 2
(Date:10/29/2014)... certain prostate cancer medications are linked with an increased ... congestive heart failure or prior heart attacks. Published in ... and patients weigh the benefits and risks of the ... levels of male hormones in the body to prevent ... treatment for prostate cancer. Despite its anticancer effects, ADT ...
(Date:10/28/2014)... that aims to make personalized medicine a reality for ... across British Columbia. , The "Genomics for Precision Drug ... of its kind in North America. The project is ... (BCPhA), with the research component led by a team ... Sciences (UBC). It will position the pharmacist as the ...
(Date:10/28/2014)... Uppsala University demonstrate that elderly men with self-reported ... Alzheimer,s disease than men without self-reported sleep disturbances. ... Alzheimer,s & Dementia . , The researchers ... 50 year old, between the years 1970 and ... self-reported sleep disturbances were linked to an increased ...
(Date:10/27/2014)... from Massachusetts General Hospital (MGH) investigators has identified ... activity of a key brain region in patients ... a mechanism of action behind one of the ... therapy. They also found evidence that pretreatment ... which patients are likely to respond to that ...
(Date:10/27/2014)... adopt a new therapy by watching others use it, ... , New technology is like an influential colleague -- ... reminded every five to seven days , CHICAGO ... when they are persuaded to do so by an influential ... adopting innovations also have relevance for business, education and research. ...
Breaking Medicine News(10 mins):Health News:Prostate cancer medications linked with increased risk of heart-related deaths in men with cardiovascular problems 2Health News:Genomics helps pharmacists target the right drugs for the right patient 2Health News:PET scans reveal how psychodynamic therapy for depression may change brain function 2Health News:PET scans reveal how psychodynamic therapy for depression may change brain function 3Health News:Persuading doctors to quickly adopt new treatments 2Health News:Persuading doctors to quickly adopt new treatments 3
... recent study accepted for publication in The Endocrine Society,s ... found that postmenopausal women who smoke have higher androgen ... levels being highest in heavy smokers. Previous studies ... are potential risk factors for breast and endometrial cancer ...
... FOR AUG. 31, 2011, ARLINGTON, Va.] Immunizations, including ... protect children from life-threatening pneumonia, according to new guidelines ... Infectious Diseases Society of America (IDSA)., The guidelines, which ... (CAP) in infants and children, place preventing bacterial pneumonia ...
... Research in Marketing Science by Professor Kamel Jedidi, ... Business School; Professor Oded Netzer, Philip H. Geier ... Professor Ricardo Montoya, Department of Industrial Engineering, University ... can maximize the return on marketing investments ...
... Aug. 30 (HealthDay News) -- Nearly one in 10 women in ... new study finds, and they could face a slightly higher risk ... doesn,t prove that so-called "child marriage" causes the increased risk of ... September issue of the journal Pediatrics . Still, the ...
... HealthDay Reporter , TUESDAY, Aug. 30 (HealthDay ... panel began a two-day meeting Tuesday on silicone breast ... post-approval safety studies. After being banned for 14 ... silicone gel-filled breast implants for breast reconstructive surgery and ...
... More and more, patients show up to appointments with hypertension ... products that they hope will help lower their blood pressure. ... products will do any good, or if they will cause ... shift where an increasing number of people want to avoid ...
Cached Medicine News:Health News:Smoking after menopause may increase sex hormone levels 2Health News:IDSA/PIDS announce guidelines for treating pneumonia in children 2Health News:IDSA/PIDS announce guidelines for treating pneumonia in children 3Health News:IDSA/PIDS announce guidelines for treating pneumonia in children 4Health News:Research identifies marketing mix strategy for pharmaceutical firms 2Health News:Women Married Before Age 18 at Higher Risk of Mental Woes: Study 2Health News:Women Married Before Age 18 at Higher Risk of Mental Woes: Study 3Health News:FDA Focuses on Silicone Breast Implant Safety Studies 2Health News:FDA Focuses on Silicone Breast Implant Safety Studies 3Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 2Health News:Beyond pills: Cardiologists examine alternatives to halt high blood pressure 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: